Damora Therapeutics, Inc.
(DMRA - NASDAQ)
30,06 USD
📋 Profilo Aziendale

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America.

|